View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
THURSDAY, June 7 (HealthDay News) -- Treatment of major depressive disorder (MDD) in adolescents can reduce the likelihood of subsequent substance use disorders (SUD), but does not reduce alcohol use disorders (AUD), according to a study published in the April issue of the Journal of Consulting and Clinical Psychology.
Jon Curry, Ph.D., from the Duke University Medical Center in Durham, N.C., and colleagues followed 192 adolescents who had participated in the Treatment for Adolescents with Depression Study (TADS). Participants had no previous AUD or SUD diagnosis and were allocated to cognitive behavior therapy, fluoxetine, a combination of therapy and fluoxetine, or placebo. Patients were assessed using the TADS treatment response rating and a more restrictive symptom count rating. Over five years of follow-up, interviews were completed at six- or 12-month intervals to assess AUD or SUD onset as well as MDD recovery and recurrence.
The researchers found that, regardless of the measure of positive response, achieving a positive response to treatment predicted a lower rate of subsequent SUD but was unrelated to subsequent AUD. Neither outcome was affected by the type of initial MDD treatment. Later AUD or SUD was predicted by greater involvement with alcohol or drugs prior to depression treatment, older age (for AUD), and more comorbid disorders (for SUD). AUD preceded MDD recurrence in 24 of 25 cases with recurrent MDD and AUD.
"Effective short-term adolescent depression treatment significantly reduces the rate of subsequent SUD but not AUD," the authors write. "Alcohol or drug use should be assessed prior to adolescent MDD treatment and monitored even after MDD recovery."
Several authors disclosed financial ties to Eli Lilly, which manufactures fluoxetine.
Full Text (subscription or payment may be required)
Find in-depth content on major issues provided by leading companies in partnership with NursingCenter.com
BD Safety Beyond Needlestick Prevention Learning Center
Sponsored by BD Medical
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top